Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Maple syrup as a sports drink? new study tests its power for cyclists

NCT ID NCT07389837

Symptom relief Sponsor: Université de Montréal Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether maple syrup, mixed with water and electrolytes, can improve cycling performance in trained male cyclists. Thirty-two participants will drink different amounts of maple syrup or a placebo during long rides. Researchers will measure how fast they finish a 20-kilometer time trial and how their bodies use energy.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
maple syrup
What this could lead to
If it works, this could show that maple syrup is a natural, well-tolerated carbohydrate source for endurance athletes.
What could go wrong
This is a small, early-stage trial in healthy male cyclists only. Results may not apply to other athletes or the general public.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 32 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age: 18-45 years. * Relative VO2max: \>55 mL·min-¹·kg-¹ for level 3; \>65 mL·min-¹·kg-¹ for level 4. * Peak Power Output (PPO): \>4.6 W·kg-¹ (absolute PPO \>320 W). * Training History: \>5 hours/week of cycling-specific training; \>1 year of consistent endurance training. * No history of metabolic disorders, gastrointestinal issues, or contraindications to exercise testing. Exclusion Criteria: * Current or past metabolic disorders (diabetes, metabolic syndrome) * Cardiovascular disease or abnormal ECG at rest * Gastrointestinal disorders (IBS, Crohn's, celiac disease) * Food allergies or intolerances (particularly maple, fructose) * Current use of medications affecting metabolism * Smoking or nicotine use * Alcohol consumption \>14 units/week * Recent illness or injury (\<4 weeks) * Participation in other clinical trials (\<3 months) * Unable to maintain consistent training during study period

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Carbohydrate intolerance are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

glucose-galactose malabsorption Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Carbohydrate intolerance Endurance cycling performance Exercise Sport nutrition

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre EPIC

    Montreal, Quebec, H1T 1N6, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.